Aqr Capital Management LLC Opti Nose, Inc. Transaction History

Aqr Capital Management LLC

  • $75.6 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$2.35 - $3.16 $100,643 - $135,333
-42,827 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.91 - $3.83 $79,314 - $104,390
27,256 Added 175.04%
42,827 $133,000
Q1 2021

May 17, 2021
BUY
$3.47 - $4.75 $54,031 - $73,962
15,571 New
15,571 $57,000
Q4 2020

Feb 16, 2021
SELL
$3.2 - $4.98 $45,241 - $70,407
-14,138 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$3.69 - $7.09 $52,169 - $100,238
14,138 New
14,138 $55,000

Others Institutions Holding OPTN

# of Institutions
2
Shares Held
5.29M
Call Options Held
0
Put Options Held
0
View Full List

About OptiNose, Inc.

OPTN Quotes by TradingView
  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $762M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email